In This Article:
CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $9.2 million in its first quarter.
The Chicago-based company said it had a loss of 6 cents per share.
The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.
The company posted revenue of $60.1 million in the period, which also beat Street forecasts. Four analysts surveyed by Zacks expected $57.4 million.
Xeris Biopharma expects full-year revenue in the range of $260 million to $275 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS